Future Research Will Involve Combination Studies for Merkel Cell Carcinoma
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey explains the impact of data on future research, stating that avelumab is the only FDA approved drug for Merkel Cell Carcinoma, and...
Author: aacr2017
Added: 04/27/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts